Aptose Biosciences Beheer
Beheer criteriumcontroles 3/4
Momenteel beschikken wij niet over voldoende informatie over de CEO.
Belangrijke informatie
William Rice
Algemeen directeur
US$924.7k
Totale compensatie
Percentage CEO-salaris | 67.4% |
Dienstverband CEO | 11yrs |
Eigendom CEO | 0.2% |
Management gemiddelde ambtstermijn | 3.5yrs |
Gemiddelde ambtstermijn bestuur | 11yrs |
Recente managementupdates
Recent updates
Here's Why We're Watching Aptose Biosciences' (TSE:APS) Cash Burn Situation
Mar 26We're Keeping An Eye On Aptose Biosciences' (TSE:APS) Cash Burn Rate
Dec 08We're Keeping An Eye On Aptose Biosciences' (TSE:APS) Cash Burn Rate
Aug 05We Think Aptose Biosciences (TSE:APS) Needs To Drive Business Growth Carefully
Apr 02Companies Like Aptose Biosciences (TSE:APS) Are In A Position To Invest In Growth
Sep 30Aptose Biosciences Inc. (TSE:APS) Insiders Have Been Selling
Feb 07Is Aptose Biosciences Inc.'s (TSE:APS) Shareholder Ownership Skewed Towards Insiders?
Jan 03We're Not Very Worried About Aptose Biosciences' (TSE:APS) Cash Burn Rate
Nov 29Jotin Marango Is The Senior VP & Chief Business Officer of Aptose Biosciences Inc. (TSE:APS) And They Just Sold 26% Of Their Shares
Jul 11Aptose Biosciences Inc. (TSE:APS) Insiders Have Been Selling
Jun 27Analyse CEO-vergoeding
Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
---|---|---|---|
Jun 30 2024 | n/a | n/a | -US$40m |
Mar 31 2024 | n/a | n/a | -US$47m |
Dec 31 2023 | US$925k | US$623k | -US$51m |
Sep 30 2023 | n/a | n/a | -US$49m |
Jun 30 2023 | n/a | n/a | -US$48m |
Mar 31 2023 | n/a | n/a | -US$44m |
Dec 31 2022 | US$2m | US$599k | -US$42m |
Sep 30 2022 | n/a | n/a | -US$56m |
Jun 30 2022 | n/a | n/a | -US$58m |
Mar 31 2022 | n/a | n/a | -US$61m |
Dec 31 2021 | US$2m | US$582k | -US$65m |
Sep 30 2021 | n/a | n/a | -US$56m |
Jun 30 2021 | n/a | n/a | -US$58m |
Mar 31 2021 | n/a | n/a | -US$60m |
Dec 31 2020 | US$12m | US$582k | -US$55m |
Sep 30 2020 | n/a | n/a | -US$48m |
Jun 30 2020 | n/a | n/a | -US$42m |
Mar 31 2020 | n/a | n/a | -US$32m |
Dec 31 2019 | US$2m | US$562k | -US$26m |
Sep 30 2019 | n/a | n/a | -US$25m |
Jun 30 2019 | n/a | n/a | -US$24m |
Mar 31 2019 | n/a | n/a | -US$28m |
Dec 31 2018 | US$2m | US$540k | -US$29m |
Sep 30 2018 | n/a | n/a | -US$26m |
Jun 30 2018 | n/a | n/a | -US$23m |
Mar 31 2018 | n/a | n/a | -US$15m |
Dec 31 2017 | US$983k | US$520k | -US$12m |
Compensatie versus markt: De totale vergoeding ($USD 924.67K ) William } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de Canadian markt ($USD 172.65K ).
Compensatie versus inkomsten: De vergoeding van William is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.
CEO
William Rice (65 yo)
11yrs
Tenure
US$924,668
Compensatie
Dr. William G. Rice, Ph D., had served as an Independent Director of Oncolytics Biotech Inc. since June 08, 2015 until June 30, 2021. He has been the Chief Executive Officer and President of Aptose Bioscie...
Leiderschapsteam
Naam | Positie | Tenure | Compensatie | Eigendom |
---|---|---|---|---|
Chairman | 11yrs | US$924.67k | 0.19% CA$ 18.5k | |
Senior VP | 2.3yrs | US$611.37k | 0.040% CA$ 4.0k | |
Senior VP & Chief Medical Officer | 4.8yrs | US$750.08k | 0.040% CA$ 4.0k | |
Senior Vice President of Regulatory Affairs | 1.3yrs | geen gegevens | geen gegevens |
3.5yrs
Gemiddelde duur
61yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van APS wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.5 jaar).
Bestuursleden
Naam | Positie | Tenure | Compensatie | Eigendom |
---|---|---|---|---|
Chairman | 11yrs | US$924.67k | 0.19% CA$ 18.5k | |
Independent Director | 17.1yrs | US$127.68k | 0.0024% CA$ 233.9 | |
Independent Director | 2.1yrs | US$132.17k | 0.094% CA$ 9.2k | |
Lead Independent Director | 17.1yrs | US$172.17k | 0.0080% CA$ 780.1 | |
Member of Scientific Advisory Board | no data | geen gegevens | geen gegevens | |
Member of Scientific Advisory Board | no data | geen gegevens | geen gegevens | |
Independent Director | 9.8yrs | US$123.67k | 0.19% CA$ 18.2k | |
Independent Director | 13.5yrs | US$122.68k | 0.0055% CA$ 540.3 | |
Chairman of Scientific Advisory Board | 11yrs | geen gegevens | geen gegevens | |
Member of Scientific Advisory Board | 9.6yrs | geen gegevens | geen gegevens | |
Independent Director | 6.2yrs | US$123.67k | 0% CA$ 0 |
11.0yrs
Gemiddelde duur
71.5yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van APS zijn ervaren en ervaren (gemiddelde ambtstermijn van 11 jaar).